Nikan Pharmaceuticals

First-ever antiviral treatment for human papillomavirus (HPV).

  • Stage Product In Development
  • Industry Biotechnology
  • Location Boston, MA, US
  • Currency USD
  • Founded November 2006
  • Employees 1
  • Incorporation Type LLC

Company Summary

Developing the first-ever antiviral drug for treatment of human papillomavirus (HPV). Our compound is oral with anticipated twice a day dosing. Our initial therapeutic focus is recurrent respiratory papillomatosis (RRP), a serious potentially lethal orphan disease in children.

Team

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free